Andersons pediatric cardiology 1587

ProlongedQTcintervalsanddecreasedleft
ventricularcontractilityinpatientswith
propionicacidemia.JPediatr.2007;150(2):192–
197.
168.MardachR,VerityMA,CederbaumSD.
Clinical,pathologicalandbiochemicalstudiesin
apatientwithpropionicacidemiaandfatal
cardiomyopathy.MolGenetMetab.
2005;85(4):286–290.
169.RomanoS,ValayannopoulosV,TouatiG,etal.
Cardiomyopathiesinproprionicaciduriaare
reversibleafterlivertransplantation.JPediatr.
2010;136:128–134.
170.MahfoudA,DominguezCL,PerezA,etal.
Diagnosisandtreatmentofmethylmalonic
aciduria;acasereport].InvestClin.
2007;48(1):99–105.
171.PradaCE,JasmiFA,KirkEP,etal.Cardiac
diseaseinmethylmalonicacidemia.JPediatr.
2011;159:862–864.
172.ChandlerRJ,TsaiMS,DorkoK,etal.
Adenoviral-mediatedcorrectionof
methylmalonyl-CoAmutasedeficiencyin
murinefibroblastsandhumanhepatocytes.BMC
MedGenet.2007;8:24.
173.PierreG,MacdonaldA,GrayG,etal.
Prospectivetreatmentincarnitine-acylcarnitine


translocasedeficiency.JInheritMetabDis.
2007;30:815.

174.BonnefontJP,DemaugreF,Prip-BuusC,etal.
Carnitinepalmitoyltransferasedeficiencies.Mol
GenetMetab.1999;68:424–440.
175.GuertlB,NoehammerC,HoeflerG.Metabolic
cardiomyopathies.IntJExpPathol.
2000;81:349–372.
176.BeightonP.CardiacabnormalitiesinEhlers–
danlossyndrome.BrHeartJ.1969;31:227–232.
177.AntaniJ,SrinivasHV.Ehlers–danlossyndrome
andcardiovascularabnormalities.Chest.
1973;63:214–217.
178.LeierCV,CallTD,FulkersonPK,WooleyCF.
ThespectrumofcardiacdefectsinEhler–danlos
syndrometypesIandIII.AnnInternMed.
1980;92:171–178.
179.McDonnellNB,GormanBL,MandelKW,etal.
Echocardiographicfindingsinclassicaland
hypermobileEhlers-danlossyndromes.AmJ
MedGenetA.2006;140(2):129–136.
180.GermainDP.Ehlers-danlossyndrometypeIV.
OrphanetJRareDis.2007;2:32.
181.PepinM,SchwarzeU,Superti-FurgaA,Byers
PH.ClinicalandgeneticfeaturesofEhlersdanlossyndrometypeIV,thevasculartype.N
EnglJMed.2000;342(10):673–680.


182.HiratzkaLF,BakrisGL,BeckmanJA,etal.2010
ACCF/AHA/AATS/ASA/SCA/SCAI/SIR/STS/SVM
guidelinesforthediagnosisandmanagementof
patientswiththoracicaorticdisease.Circulation.

2010;121:e266–e369.
183.SchwarzeU,HataR,McKusickVA,etal.Rare
autosomalrecessivecardiacvalvularforof
Ehlers-danlossyndromeresultsfrommutations
intheCOL1a2genethatactivatethenonsensemediatedRNAdecaypathway.AmJHum
Genet.2004;74(5):917–930.
184.WeirEK,JoffeHS,BlaufussAH,BeightonP.
Cardiovascularabnormalitiesincutislaxa.EurJ
Cardiol.1977;5(3):255–261.
185.SzaboZ,CrepeauMW,MitchellAL,etal.
Aorticaneurysmaldiseaseandcutislaxacaused
bydefectsintheelastingene.JMedGenet.
2006;43(3):255–258.
186.KardelenF,AkcurinG,ErtugH,TacoyS,
CiftciogluA.Supravalvularaorticstenosisin
cutislaxasyndrome:acasereport.IntJCardiol.
2002;83(2):167–168.
187.TassabehjiM,UrbanZ.Congenitalheartdisease:
moleculardiagnosticsofsupravalvularaortic
stenosis.MethodsMolMed.2006;126:129–156.
188.HucthagowderV,SausgruberN,KimKH,etal.
Fibulin-4:anovelgeneforanautosomal